Advertisement
Advertisement

AMPH

AMPH logo

Amphastar Pharmaceuticals, Inc.

26.50
USD
Sponsored
+0.35
+1.35%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

26.61

+0.10
+0.39%

AMPH Earnings Reports

Positive Surprise Ratio

AMPH beat 32 of 40 last estimates.

80%

Next Report

Date of Next Report
Feb 25, 2026
Estimate for Q4 25 (Revenue/ EPS)
$194.29M
/
$0.94
Implied change from Q3 25 (Revenue/ EPS)
+1.28%
/
+1.08%
Implied change from Q4 24 (Revenue/ EPS)
+4.16%
/
+2.17%

Amphastar Pharmaceuticals, Inc. earnings per share and revenue

On Nov 06, 2025, AMPH reported earnings of 0.93 USD per share (EPS) for Q3 25, beating the estimate of 0.84 USD, resulting in a 10.58% surprise. Revenue reached 191.84 million, compared to an expected 188.42 million, with a 1.81% difference. The market reacted with a -0.83% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analysts forecast an EPS of 0.94 USD, with revenue projected to reach 194.29 million USD, implying an increase of 1.08% EPS, and increase of 1.28% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Teva Pharmaceutical Industries Limited - ADR
Report Date
Jan 28, 2026 For Q4 25
Estimate
$0.69
Actual
$0.96
Surprise
+38.55%
logo
Dr. Reddy's Laboratories Limited - ADR
Report Date
Jan 21, 2026 For Q3 26
Estimate
$13.86
Actual
$14.65
Surprise
+5.66%
FAQ
For Q3 2025, Amphastar Pharmaceuticals, Inc. reported EPS of $0.93, beating estimates by 10.58%, and revenue of $191.84M, 1.81% above expectations.
The stock price moved down -0.83%, changed from $24.23 before the earnings release to $24.03 the day after.
The next earning report is scheduled for Feb 25, 2026.
Based on 9 analysts, Amphastar Pharmaceuticals, Inc. is expected to report EPS of $0.94 and revenue of $194.29M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement